Categories: HealthcareNews

Digital Health Visionary Joins True to Bring Expertise in Equitable Healthcare

RALEIGH-DURHAM, N.C.–(BUSINESS WIRE)–True, the only tech and data-first global talent platform, announced today the addition of André Blackman as a partner in True Search’s Healthcare practice. He brings to True his extensive experience across the healthcare, public health and digital health landscapes to help companies build an equitable and inclusive future of health.


“André’s deep background in digital health has afforded him a wealth of valuable relationships and insights into this dynamic space,” said Jessica Johnson, co-Head of the Healthcare & Life Sciences practices. “That expertise and his leadership in promoting diversity in healthcare, positions him to significantly enhance our practice offerings.”

Prior to joining True Search, Blackman was founder and CEO of Onboard Health, a executive search and advisory firm dedicated to creating a more diverse healthcare workforce. With Onboard Health, Blackman advised organizations on sustainable use of health technology, helped companies foster diverse and inclusive leadership, and provided executive search and strategic advisory services. Blackman brings a wealth of experience from collaborations with notable companies like Rock Health, the American Medical Association, Johnson & Johnson and Verily. He works across asset classes—from startups to large public organizations.

“True and I share a commitment to building the future of healthcare with sustainability, inclusion and equity at its core, and I’m excited to contribute to True’s renowned Healthcare practice to further this mission in digital health,” said Blackman.

Blackman’s insights on inclusive healthcare innovation have garnered recognition in notable publications, including Business Insider, Fortune, Forbes, NPR, and U.S. News and World Report. He was named one of Fortune Magazine’s 2020 “40 Under 40” in Healthcare and contributes to Forbes and Newsweek on the future of work.

ABOUT TRUE

True is the world’s only tech and data-first talent management platform. The sixth largest in its industry, True leverages 10+ years worth of proprietary data, market insights, and talent lifecycle expertise, to help companies make high-impact talent decisions quickly. True’s unmatched products and services include True Search (retained executive search), TrueBridge (advisory, interim, and fractional executive placement), Thrive (Talent CRM software), Search Essentials (tech-enabled hiring services), AboveBoard (inclusive executive career community), and Jopwell (leading diversity tech platform for early-mid career professionals). True also backs promising companies through its investment brands True Equity and Vera Equity.

Contacts

Sarah Mikhailova / VP, Communications

sarah@trueplatform.com

Staff

Recent Posts

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…

42 minutes ago

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

12 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

15 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

15 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

15 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

15 hours ago